Systematic Reviews Open Access
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Jun 20, 2024; 14(2): 94562
Published online Jun 20, 2024. doi: 10.5662/wjm.v14.i2.94562
Non-enzymatic methods for isolation of stromal vascular fraction and adipose-derived stem cells: A systematic review
Vamsi Krishna Mundluru, MJ Naidu, Ravi Teja Mundluru, Department of Orthopaedics, MJ Naidu Super Speciality Hospital, Vijayawada 520002, Andhra Pradesh, India
Vamsi Krishna Mundluru, MJ Naidu, Ravi Teja Mundluru, Naveen Jeyaraman, Madhan Jeyaraman, Department of Regenerative Medicine, StemC Clinics, Vijayawada 520002, Andhra Pradesh, India
Naveen Jeyaraman, Madhan Jeyaraman, Department of Orthopaedics, ACS Medical College and Hospital, Dr. MGR Educational and Research Institute, Chennai 600077, Tamil Nadu, India
Naveen Jeyaraman, Sathish Muthu, Madhan Jeyaraman, Department of Orthopaedics, Orthopaedic Research Group, Coimbatore 641045, Tamil Nadu, India
Sathish Muthu, Department of Orthopaedics, Government Medical College and Hospital, Karur 639004, Tamil Nadu, India
Sathish Muthu, Department of Biotechnology, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore 641021, Tamil Nadu, India
Swaminathan Ramasubramanian, Department of Orthopaedics, Government Medical College, Omandurar Government Estate, Chennai 600002, Tamil Nadu, India
ORCID number: Naveen Jeyaraman (0000-0002-4362-3326); Sathish Muthu (0000-0002-7143-4354); Swaminathan Ramasubramanian (0000-0001-8845-8427); Madhan Jeyaraman (0000-0002-9045-9493).
Author contributions: Naidu M contributed to conceptualization; Mundluru VK, Mundluru RT, and Jeyaraman N contributed to data collection; Mundluru VK, Jeyaraman M, and Ramasubramanian S contributed to manuscript writing; Muthu S contributed to manuscript revision; Muthu S and Jeyaraman M contributed to proofreading; Jeyaraman M contributed to administration.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Madhan Jeyaraman, MS, PhD, Assistant Professor, Research Associate, Department of Orthopaedics, ACS Medical College and Hospital, Dr. MGR Educational and Research Institute, Velappanchavadi, Chennai 600077, Tamil Nadu, India. madhanjeyaraman@gmail.com
Received: March 20, 2024
Revised: May 3, 2024
Accepted: May 30, 2024
Published online: June 20, 2024
Processing time: 85 Days and 22.9 Hours

Abstract
BACKGROUND

Adipose-derived stem cells (ADSCs) and the stromal vascular fraction (SVF) have garnered substantial interest in regenerative medicine due to their potential to treat a wide range of conditions. Traditional enzymatic methods for isolating these cells face challenges such as high costs, lengthy processing time, and regu-latory complexities.

AIM

This systematic review aimed to assess the efficacy and practicality of non-enzymatic, mechanical methods for isolating SVF and ADSCs, comparing these to conventional enzymatic approaches.

METHODS

Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, a comprehensive literature search was conducted across multiple databases. Studies were selected based on inclusion criteria focused on non-enzymatic isolation methods for SVF and ADSCs from adipose tissue. The risk of bias was assessed, and a qualitative synthesis of findings was performed due to the methodological heterogeneity of the included studies.

RESULTS

Nineteen studies met the inclusion criteria, highlighting various mechanical techniques such as centrifugation, vortexing, and ultrasonic cavitation. The review identified significant variability in cell yield and viability, and the integrity of isolated cells across different non-enzymatic methods compared to enzymatic procedures. Despite some advantages of mechanical methods, including reduced processing time and avoidance of enzymatic reagents, the evidence suggests a need for optimization to match the cell quality and therapeutic efficacy achievable with enzymatic isolation.

CONCLUSION

Non-enzymatic, mechanical methods offer a promising alternative to enzymatic isolation of SVF and ADSCs, potentially simplifying the isolation process and reducing regulatory hurdles. However, further research is necessary to standardize these techniques and ensure consistent, high-quality cell yields for clinical applications. The development of efficient, safe, and reproducible non-enzymatic isolation methods could significantly advance the field of regenerative medicine.

Key Words: Adipose-derived stem cells; Stromal vascular fraction; Regenerative medicine; Non-enzymatic isolation; Mechanical separation techniques

Core Tip: This study highlights the superiority of non-enzymatic methods as alternatives for the isolation of stromal vascular fraction from adipose tissue. It emphasizes the necessity of standardizing these methods to ensure the procurement of consistent and high-quality cell yields suitable for a range of clinical applications.



INTRODUCTION

Regenerative medicine has emerged as a pivotal area of interest across multiple medical specialties, driven by an in-creasing volume of literature on the potential of regenerative cells for a myriad of indications. Among various sources, adipose tissue is recognized for its significant role beyond shock absorption, thermoregulation, and energy storage; it stands out as the largest and most crucial reservoir for adipose-derived stem or stromal cells (ADSCs). These cells are predominantly found within the perivascular region of the stroma, an area characterized by a loose connective tissue matrix that houses a diverse array of cells including immune cells, erythrocytes, mesenchymal stem cells (MSCs), and other stromal components[1-4]. The ease of collection through liposuction, a minimally invasive procedure performed under local anesthesia, further underscores the accessibility of adipose tissue for regenerative therapies. Historically, the therapeutic potential of adipose tissue dates back to World War I, when Morestin first utilized fatty tissue injections to enhance wound healing in soldiers. This early application laid the groundwork for the field, which gained substantial momentum following the work of Zuk et al[5], who highlighted adipose tissue as a prime source of MSCs[5]. Recent studies have delved into the capabilities of ADSCs, particularly those within the stromal vascular fraction (SVF), focusing on their role in tissue regeneration for injuries and chronic conditions[6,7]. The SVF's rich secretome and the multipotent nature of its cellular constituents underscore its therapeutic potential[8,9].

However, the conventional method of isolating ADSCs from adipose tissue, primarily through enzymatic dissociation, poses significant challenges, including operational complexity and the need for specialized equipment, rendering it impractical for immediate surgical application[10,11]. This enzymatic process, despite its efficacy in isolating SVFs, disrupts the stem cell niche and necessitates compliance with good manufacturing practice standards, as defined by regulatory authorities[12,13]. Such limitations have catalyzed interest in mechanical stromal-cell separation techniques, exemplified by the development of nanofat by Tonnard et al[2], which offers a non-enzymatic alternative for cell isolation. Despite the advent of intraoperative isolation techniques that promise to circumvent the challenges of enzymatic methods, there remains a paucity of research comparing the efficacy, cell yield, and phenotype of cells isolated through these novel mechanical methods to the traditional enzymatic approach[11,14]. This knowledge gap is particularly sig-nificant given the logistical and operational constraints faced by peripheral hospitals, which often lack the resources for the labor-intensive enzymatic isolation of ADSCs[15].

This systematic review aimed to critically assess the therapeutic potential of non-enzymatic methods for producing SVF, comparing these newer mechanical isolation techniques against the established enzymatic method. By evaluating the quality and quantity of SVF obtained through non-enzymatic methods, this review seeks to address a critical gap in the literature and validate the feasibility of these approaches for regenerative medicine applications.

MATERIALS AND METHODS

This systematic review was meticulously designed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, ensuring a structured and transparent methodology. The PRISMA flow diagram, illustrating the search and selection process, is presented in Figure 1[16]. The foundation of our search strategy was the well-established Population, Intervention, Comparison, and Outcome framework[17], which facilitated a focused and comprehensive literature search. It is noteworthy to mention that this investigation did not undergo formal registration, as it was developed primarily for academic purposes, specifically as part of a master’s thesis project.

Figure 1
Figure 1 Preferred reporting items for systematic reviews and meta-analyses flow diagram of the included studies.
Eligibility criteria

The selection of studies for inclusion in this systematic review was governed by the precise inclusion and exclusion criteria tailored to the objectives of our investigation.

Inclusion criteria: Our review targeted studies that discussed non-enzymatic isolation procedures for the isolation of the SVF from adipose tissue. We included studies that utilized the adipose fraction obtained from lipoaspirate and those that evaluated the effectiveness of centrifugation forces, sonication, or red blood cell (RBC) lysis buffer. Studies were also considered if they compared non-enzymatic isolation techniques directly with enzymatic methods.

Exclusion criteria: We excluded studies published before the year 2000 and those not written in English to maintain a contemporary focus and ensure comprehension across the research team. Articles that solely utilized enzymatic isolation techniques or combined enzymatic with mechanical methods for SVF extraction were not considered. Furthermore, case studies, case series, and reviews focusing exclusively on adipose tissue processing techniques for fat grafting purposes were disregarded to maintain a clear focus on SVF isolation methodologies.

Information sources and search strategy

A comprehensive search was conducted across several databases, including The Cochrane Central Register of Controlled Trials, Embase (OvidSP), and PubMed, to identify relevant studies. The search strategy was meticulously crafted, combining keywords and phrases related to the population of interest (adipose stromal cells, ADSCs, adipose stem cells, stem cells, and SVF) with terms associated with the intervention (cell separation, isolation, dissociation, and isolation system) and comparison elements (non-enzymatic, mechanical, vibration, and sonic). This approach ensured a broad yet focused retrieval of pertinent literature.

Study selection and data collection process

Given the nature of this investigation as a master’s thesis, the article selection and data collection processes were undertaken by a single author. This involved screening the identified records based on the predefined eligibility criteria, followed by a thorough examination of the full texts of potentially relevant studies. This approach, while somewhat limited by the capacity of a single researcher, ensured a consistent and focused evaluation of the literature.

Risk of bias across studies

To address the potential risk of bias across the included studies, several measures were implemented. The variability in SVF analysis result variables and the methodological heterogeneity inherent in the investigated isolation techniques necessitated a qualitative synthesis rather than a quantitative meta-analysis. To this end, the Modified IFATS/ISCT Index Score was utilized to provide a comprehensive overview of the outcome measures reported in each study. Additionally, the potential for publication bias, particularly in studies where authors may have conflicts of interest, was carefully considered. Disclosure agreements and funding sources were examined for each study to assess the risk of bias and ensure transparency in the reported findings. The Office of Health Assessment and Translation (OHAT) Risk of Bias Tool for Human and Animal Studies was used to assess the risk of bias and internal validity[18]. Six questions from the tool relating to cross-sectional research were assessed for each study. Each question required a score that reflected the risk of bias: As per the original tool, ‘++’ reflects a low risk of bias, ‘+’ reflects probably a low risk of bias, ‘-‘ reflects probably a high risk of bias, and ‘- -’ (double negative) reflects a high risk of bias.

RESULTS

The outcomes of this systematic review, synthesized in a Prisma flowchart in Figure 1, highlight the rigorous me-thodology adopted from the initial literature search to the final inclusion of studies. The review was initiated with an exhaustive search across multiple databases, yielding a preliminary tally of 1288 articles. This was supplemented by five additional studies identified from alternative sources, bringing the total to 1293 articles considered for inclusion. The elimination of duplicates pared down this number to 928 unique articles, indicating the extensive nature of the initial search and the importance of reducing redundancy to streamline the review process.

A critical screening of titles further narrowed the pool to 146 articles, with 782 being excluded due to their lack of alignment with the review's stringent preliminary criteria. This step is essential in ensuring that only articles with the most relevant content proceed to the next stage, thereby maintaining the precision and focus of the review. The in-depth evaluation of 88 full-text articles for eligibility resulted in the exclusion of 58 articles. The reasons for these exclusions were varied but primarily related to a divergence from the review's central theme or failure to meet the established inclusion criteria, emphasizing the review's commitment to methodological rigor and thematic relevance. Particular attention was given to the types of studies considered, with a focus on excluding reviews (systematic reviews and literature reviews), surveys, case reports, and other research designs not directly contributing to the review's objectives. This led to the exclusion of 12 studies[11,14,19-28] due to factors such as thematic inconsistency and methodological flaws, highlighting the critical evaluation process in maintaining the integrity of the review. Furthermore, the research designs of two additional studies[29,30] resulted in their exclusion, underscoring the stringent adherence to the review's methodological standards.

Upon meticulous consideration, 19 articles were selected for inclusion, each offering significant insights into the research question through diverse methodological approaches. This selection underscores the necessity of a systematic and objective evaluation to identify studies that significantly contribute to understanding the topic. These studies collectively span a broad range of methodologies, from quantitative analyses to qualitative assessments, reflecting the complexity of the research field and the evolving nature of its investigative methods. Table 1 presents a detailed comparison of cell separation techniques, from mechanical to enzymatic methods, and their impact on cell yield, viability, and efficiency[31-47]. Techniques such as the vibrating shaker and centrifugation, as employed by Raposio et al[31], alongside innovative tools like the LipocubeNano and Tulip NanoTransfer Kit by Cohen et al[32], are highlighted for their procedural variability and outcomes in terms of cell viability and counts. The pioneering concept of nanofat by Tonnard et al[2] and the comparison of mechanical disaggregation vs enzymatic dissociation by Sesé et al[33] are notable for demonstrating significant differences in cell yields. Additionally, the table reviews procedural innovations, such as the use of the Lipogems system reported by Bianchi et al[34], which indicated a higher percentage of mature pericytes and MSCs, showcasing the critical role of methodology in optimizing cell isolation and viability for therapeutic purposes. The inclusion of data on processing techniques by Bright et al[35] and a comparison of cell yields across different systems by Gentile et al[36] provide essential insights into the efficiency and effectiveness of various separation methods. Table 2 represents the risk of bias in the included studies based on the OHAT criteria. This comprehensive analysis underscores the methodological nuances that influence the advancement of regenerative medicine and cell-based therapies, serving as a pivotal reference in understanding the landscape of SVF and ADSC separation techniques.

Table 1 Summary of the included studies in the systematic review.
Ref.
Method of separation
No. of samples
Open/closed
Time taken
Cell counts
Significance
Raposio et al[31]Vibrating shaker at 6000 rpm for 6 min followed by centrifugation at 1600 rpm for 6 min-Open15 min125000 nucleated cells per cc of lipoaspirate, but only about 5% of these were found to be progenitor cellsA pellet is formed at the end
Cohen et al[32]LipocubeNano decanted for 3 min in a syringe: First, Port 1 is used to pass the fat graft once, resulting in 1 mm parcel sizes. After that, the fat is transferred 10 times back and forth between Ports 2 and 3, smoothing and homogenizing the fat tissue. Finally, to produce the final product, Nanofat, the fat was transferred once from Port 3 to Port 4 via a 500-micron single filter. Tulip NanoTransfer Kit. After decantation for 3 min, transfer millifat from Port 1 to 2. Flush the fat between Ports 2 and 3 for 10 times. Collect the final product by transferring fat from Ports 3 to 4 in a single stroke10 patientsClosedNot mentioned (Approximately less than 10 min for both methods)LipocubeNano resulted in relatively high cell counts (2.24 × 106/mL) and cell viability (96.75%), whereas Tulip’s NanoTransfer method resulted in a lower cell count of 1.44 × 106/mL and cell viability of 96.75%-
Tonnard et al[2]Lipoaspirate is washed and rinsed followed by 30 passes done between two 10 mL syringes connected by leur lock and the resultant whitish fluid is filtered over a sterile nylon cloth67 casesOpenNot mentioned (Approximately less than 10 min)1975000 cells per 100 mL of lipoaspirateIntroduced the concept of nanofat
Sesé et al[33]Enzymatic dissociation using GID stromal vascular fraction protocol. Mechanical dissociation using Tulip. NanoTransfer Protocol20 for enzymatic and 6 for mechanicalClosedNot availableEnzymatically dissociated stromal vascular fraction resulted in 0.68 million cells/g lipoaspirate, whereas mechanically disaggregated nanofat resulted in 6.63 million cells/g lipoaspirate-
Bianchi et al[34]Lipogems-ClosedLess than 20 minThe significantly higher percentage of mature pericytes and MSCs, and lower number of hematopoietic elements, than enzymatically digested lipoaspirates-
Bright et al[35]Centrifugation for 2 min at 200 g of lipoaspirate. Followed by an ultrasonic cavitation device probe using Hielschler UP200s set at 50% amplitude and cycle of 0.4 for 1 min with the probe lowered and 30 s at the top of the tube. The resultant fluid is subjected to centrifugation for 5 min at 300 g with a temperature not rising above 43 degrees and preferably not over 37 degrees-Open-169 million cells were injected intraarticularly for a patient with anterior cruciate tear mentioned but not specified the volumeDescribed as a patented procedure. Different modifications of this technique also have been described based on the indication and site of therapeutic application
Gentile et al[36]Mystem system – washing and filtration. Fastem- Filtration and centrifugation for 10 min at 1700 rpm10 for Fastem and 10 for MystemClosed for both systemsNot availableCell yield achieved with Mystem is less than that with Fastem and Cytori (enzymatic isolation technique)Improved contour seen after breast reconstruction with fat grafts enriched with ADSCs from Fastem (equal to Cytori) greater than Mystem
van Dongen et al[22]Centrifuged at 300 rpm for 2.5 min followed by non-enzymatic dissociation performed by pushing the lipoaspirate to and through a fractionator 30 times. The resultant fluid is centrifuged for 2.5 min at 3000 rpm-Open10 min2.7 × 106/mL-
Chaput et al[37]Vortexing and centrifuging. Vibrating shaker for 6 min at 3200 rpm followed by centrifugation for 6 min at 558 g followed by 100 micrometre sieves followed by centrifugation for 10 min21Open22 minThe percentage of ADSCs in SVF extracted by vortexing and centrifugation, dissociation by inter-syringe process, and enzymatic isolation techniques are 5.81 ± 1.3, 38.11 ± 5.1, and 21.45 ± 2.52, respectivelyFinal pellet for vortexing and centrifuging
Dissociation by inter-syringe processing 30 passes through leur lock connected syringes passed through 100-micrometre sieve followed by centrifugation for 10 minOpen11 minsFinal pellet for dissociation by inter-syringe processing
Copcu et al[38]Centrifuged at 500 g for 2 min. Adinizing was first performed with a 4000-micron Adinizer; after approximately 25 passes, the cutting process was continued with the next-smaller diameter disk followed by centrifugation for 6 min at 1600 g24 patientsOpenNot mentioned93% mean viability and cell counts of 28.66 to 88.88 × 106 from 100 mL of condensed fatVolumes ranging from 3-12 mL can be produced depending on the indication
Rose et al[39]Sedimentation for 1 h, centrifugation at 3000 rpm for 3 min or washing with normal saline combined with 3 min of centrifugation at 3000 rpm24 fat samplesOpen-The mean cell count per high-powered field of histologically intact adipocytes was 27.1 for specimens processed by sedimentation, 14.2 for centrifuging, and 11.8 for washing-
Amirkhani et al[40]Dissected for 10 s using a blender mixer followed by sonic cavitation for 2 min at 18 MHz followed by centrifugation for 10 min at 900 g followed by suspension with 150 mM ammonium chloride for 5 min and centrifugation for 5 min at 400 g. The pellets are then resuspended in DMEM supplemented with 10% FBS and then seeded into a T25 culture flask. After 24 h, the adherent cells were used for further confirmation tests. The SVFs harvested by both methods were suspended in PBS and then incubated for 30 min at 4 °C with the antibodies conjugated with FITC against CD34, CD44, CD73, CD90, and CD105 biomarkers-OpenLess than 30 minViable cells 2.6 × 105 cells from 1 mL of fat tissue-
Victor[41]Ultrasonic cavitation performed using a 200 W generator (SONIC 200) for a range of 10 to 20 min at a frequency of about 20-30 kHz-Open-From 2 million up to 22 million stromal vascular cells per mL of adipose tissueDescribed as a patented procedure
Domenis et al[42]Fastem - automated system performing filtration and centrifugation for 10 min at 1700 rpm6ClosedNot availableOnly mentioned that cell yield from Fastem was less than Lipokit and less than CytoriEnriched grafting has greater subcutaneous thickness
Condé-Green et al[43]Centrifugation followed by vortexing for 3 min. Centrifugation followed by RBC lysis9OpenNot availablecSVF of 1.2 × 104 per mL for the first method
and 2.3 × 104 per mL for the second method
Mechanical methods have greater cells positive for CD14 than with enzymatic process which is a marker for monocytes and macrophages
Markarian et al[44]The first method involved RBC lysis of lipoaspirate and then centrifugation for 10 min at 600 g. The second and third techniques each included an additional initial stage of centrifugation at 800 g and 1280 g for 15 min, respectively10OpenNot availableThe cell yield obtained from collagenase was greater than that of mechanical and trypsin. The second and third methods produced viable cells that had not proliferated even after 14 d-
Shah et al[45]Rigorous washing in PBS with handshaking followed by centrifugation for 15 min at 900 g13Open1 h for mechanical and almost 3 h for isolation with collagenaseThe mechanical method produced 19 times fewer cells compared to the enzymatic extraction technique-
Condé-Green et al[46]Lipoaspirate is subjected to RBC lysis followed by 15 min of centrifugation at 900 g10OpenNot availableThe highest concentration of ADSCs was found in the pellet found at the bottom after centrifugation-
Baptista et al[47]The procedure followed in the same sequence. RBC lysis, centrifugation for 15 min at 900 g, resuspension in fetal bovine serum plus dimethyl sulfoxide, cryopreservation at –196 degrees centigrade13OpenMechanical processing required less timeCell yield was less with mechanical compared to enzymatic processingAdherent cells were positive for CD44, CD90, CD105, and CD34 and negative for CD45 and CD73
Table 2 Risk of bias in the included studies based on office of health assessment and translation criteria.
Ref.
Did the selection of study participants appropriate?
Did the study account for confounding and modifying variables?
Were the outcome data complete without attrition bias?
Can we be confident in exposure characterization?
Can we be confident in outcome assessment?
Were all measured outcomes reported?
Raposio et al[31]+++++++++++
Chaput et al[37]+++++++++
Cohen et al[32]++++- (NR)++
Copcu et al[38]++++++++++
Tonnard et al[2]+++++++
Sesé et al[33]+++++++
Rose et al[39]+++++++++++
Bianchi et al[34]++++++++++++
van Dongen et al[22]++++- (NR)++
Amirkhani et al[40]++++++++++++
Victor[41]++++++++++++
Bright et al[35]++-++++
Domenis et al[42]+++++- (NR)++
Gentile et al[36]+++++++
Condé-Green et al[43]++++++++++++
Markarian et al.[44]+++++++++++
Shah et al[45]++++++++++++
Condé-Green et al[46]++++++- (NR)++
Baptista et al[47]++++++++++
DISCUSSION

In the evolving landscape of regenerative medicine, the utilization of autologous cellular SVF (cSVF) for therapeutic applications represents a significant advancement. This discussion systematically reviews the efficacy, challenges, and clinical implications of mechanical vs enzymatic isolation techniques of cSVF, with a focus on their application in osteoarthritis, chronic wounds, bone and cartilage disorders, and Crohn's disease, and as vectors for drug delivery to malignancies[48-51]. The traditional enzymatic digestion method, while effective, faces several limitations including extensive processing time, high costs, and stringent regulatory challenges as outlined by the United States Food and Drug Administration[52,53].

The advent of mechanical cell separation techniques introduces a promising alternative, offering reduced processing time and potentially lower regulatory hurdles. Techniques such as centrifugation, vortexing, and manual shaking have been developed, yet their clinical applicability remains underexplored due to limited published data[31,36,42,45,54]. This gap underscores the necessity for further empirical evidence to validate the reliability and usefulness of these mechanical methods in clinical settings. Mechanical isolation techniques, including innovative automated systems like Fastem, Mystem, and Lipogems, have shown the potential to enhance outcomes in fat grafting procedures. These systems promise a streamlined isolation process within a single device, potentially mitigating risks of contamination and improving volume retention in breast reconstruction surgeries[36,42]. However, the efficiency of these mechanical methods, especially in terms of cell yield and viability, needs thorough evaluation when compared to traditional enzymatic digestion, which is known for its higher cSVF output.

A critical aspect of mechanical separation is its product outcome. Techniques developed by researchers such as Tonnard et al[2] and Bianchi et al[34] focus on producing a fat-grafting material rich in viable MSCs rather than isolating cSVF as a standalone product. This approach highlights the variability in mechanical isolation outcomes and their implications for clinical practice, emphasizing the need to delineate between methods aimed at enriching fat grafts vs those isolating cSVF for broader therapeutic applications. The time efficiency of mechanical methods presents a significant advantage over enzymatic procedures, with some requiring as brief as 30 s for processing[55]. However, the variability in cell yield, survival, and composition of the SVF obtained through mechanical means raises questions about their efficacy and the potential impact on therapeutic outcomes. Furthermore, the effects of mechanical manipulation on cell integrity and the proliferative potential of ADSCs warrant careful consideration, as repetitive processing may compromise cell yield and increase the risk of contamination[42,44,45,56].

The role of ADSCs, characterized by their immunomodulatory, angiogenic, and multipotent properties, is crucial in the context of fat graft maintenance and overall therapeutic efficacy[11,31,45,47,57,58]. The potential adverse effects of mechanical vs enzymatic isolation on these cell populations and their functional capabilities remain a pivotal area for further investigation. This exploration is essential to determine whether the differences in cell output and population composition observed with enzymatic methods translate to superior clinical outcomes, justifying their longer processing time and higher associated costs. Considering the therapeutic potential of enriching autologous adipose tissue transfers with ADSCs, the exploration of mechanical processing techniques becomes imperative. These methods offer a promising avenue for enhancing the outcomes of reconstructive and cosmetic procedures by potentially providing a safer and more efficient alternative to enzymatic digestion[25,59,60]. Nonetheless, the challenge of achieving consistent and replicable results due to the heterogeneous nature of mechanically processed SVF highlights the necessity for standardized procedures and rigorous quality control measures.

The primary limitation of this review lies in the novelty of the mechanical isolation techniques and the corresponding scarcity of comprehensive, large-scale comparative studies. The existing literature, characterized by a diversity of methods, small sample sizes, and a lack of randomized control trials, hampers the ability to draw definitive conclusions about the efficacy and safety of mechanical vs enzymatic isolation techniques. This variability and methodological heterogeneity limit the strength of the evidence base, underscoring the need for further research. Specifically, well-designed studies comparing mechanical and enzymatic isolation methods are critical to establishing standardized, efficient, and safe practices that can be broadly implemented in clinical settings. The journey toward optimizing cSVF isolation techniques for clinical application is complex and requires a multifaceted approach to research and development. As the field of regenerative medicine continues to evolve, the quest for effective, efficient, and safe methods of cell isolation remains at the forefront of scientific inquiry. The potential of cSVF to revolutionize the treatment of a wide range of conditions is immense, yet realizing this potential hinges on overcoming the current limitations and advancing our understanding of the best practices for cell isolation and application.

CONCLUSION

This systematic review meticulously evaluates the non-enzymatic methods for isolating the SVF and ADSCs from adipose tissue, offering a comprehensive comparison to the traditional enzymatic approaches. The findings underscore the promise of mechanical isolation techniques in addressing the limitations of enzymatic methods, including reducing processing time, mitigating regulatory hurdles, and potentially enhancing the safety and efficacy of cell-based regenerative therapies. Despite the demonstrated advantages of mechanical methods, such as increased procedural simplicity and the avoidance of enzymatic reagents, this review also highlights the variability in cell yield, viability, and functional integrity of the isolated cells. The current evidence suggests that while non-enzymatic methods hold significant potential for clinical application, their outcomes are varied and require further investigation to optimize cell quality and therapeutic efficacy. The scarcity of large-scale, randomized controlled trials comparing mechanical and enzymatic isolation methods signifies a crucial gap in the literature, emphasizing the need for standardized methodologies and rigorous research to establish evidence-based practices in the field of regenerative medicine. As the field advances, the development and refinement of non-enzymatic isolation techniques will be critical in realizing the full therapeutic potential of SVF and ADSCs, offering promising avenues for enhancing patient outcomes across a broad spectrum of medical conditions.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Medical laboratory technology

Country of origin: India

Peer-review report’s classification

Scientific Quality: Grade C

Novelty: Grade C

Creativity or Innovation: Grade B

Scientific Significance: Grade B

P-Reviewer: Wang G, China S-Editor: Li L L-Editor: A P-Editor: Chen YX

References
1.  Guo J, Widgerow AD, Banyard D, Toranto J, Wirth GA, Paydar K, Tocco-Tussardi I, Evans GR. Strategic sequences in fat graft survival. Ann Plast Surg. 2015;74:376-382.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 15]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
2.  Tonnard P, Verpaele A, Peeters G, Hamdi M, Cornelissen M, Declercq H. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2013;132:1017-1026.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 353]  [Cited by in F6Publishing: 350]  [Article Influence: 31.8]  [Reference Citation Analysis (1)]
3.  Friji MT. Nanofat grafting: basic research and clinical applications. Plast Reconstr Surg. 2014;134:333e-334e.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 13]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
4.  Sharma S, Muthu S, Jeyaraman M, Ranjan R, Jha SK. Translational products of adipose tissue-derived mesenchymal stem cells: Bench to bedside applications. World J Stem Cells. 2021;13:1360-1381.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 13]  [Article Influence: 4.3]  [Reference Citation Analysis (1)]
5.  Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211-228.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5703]  [Cited by in F6Publishing: 5657]  [Article Influence: 246.0]  [Reference Citation Analysis (0)]
6.  Dykstra JA, Facile T, Patrick RJ, Francis KR, Milanovich S, Weimer JM, Kota DJ. Concise Review: Fat and Furious: Harnessing the Full Potential of Adipose-Derived Stromal Vascular Fraction. Stem Cells Transl Med. 2017;6:1096-1108.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 65]  [Cited by in F6Publishing: 68]  [Article Influence: 9.7]  [Reference Citation Analysis (0)]
7.  Frese L, Dijkman PE, Hoerstrup SP. Adipose Tissue-Derived Stem Cells in Regenerative Medicine. Transfus Med Hemother. 2016;43:268-274.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 210]  [Cited by in F6Publishing: 264]  [Article Influence: 33.0]  [Reference Citation Analysis (0)]
8.  Si Z, Wang X, Sun C, Kang Y, Xu J, Hui Y. Adipose-derived stem cells: Sources, potency, and implications for regenerative therapies. Biomed Pharmacother. 2019;114:108765.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 122]  [Cited by in F6Publishing: 211]  [Article Influence: 42.2]  [Reference Citation Analysis (0)]
9.  Ong WK, Sugii S. Adipose-derived stem cells: fatty potentials for therapy. Int J Biochem Cell Biol. 2013;45:1083-1086.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 86]  [Cited by in F6Publishing: 94]  [Article Influence: 8.5]  [Reference Citation Analysis (0)]
10.  Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15:641-648.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1199]  [Cited by in F6Publishing: 1292]  [Article Influence: 117.5]  [Reference Citation Analysis (2)]
11.  Aronowitz JA, Lockhart RA, Hakakian CS. Mechanical vs enzymatic isolation of stromal vascular fraction cells from adipose tissue. Springerplus. 2015;4:713.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 148]  [Cited by in F6Publishing: 137]  [Article Influence: 15.2]  [Reference Citation Analysis (0)]
12.  Rohrich RJ, Wan D. Making Sense of Stem Cells and Fat Grafting in Plastic Surgery: The Hype, Evidence, and Evolving U.S. Food and Drug Administration Regulations. Plast Reconstr Surg. 2019;143:417e-424e.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 17]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
13.  Dai Prè E, Busato A, Mannucci S, Vurro F, De Francesco F, Riccio V, Solito S, Biswas R, Bernardi P, Riccio M, Sbarbati A. In Vitro Characterization of Adipose Stem Cells Non-Enzymatically Extracted from the Thigh and Abdomen. Int J Mol Sci. 2020;21.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 11]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
14.  Oberbauer E, Steffenhagen C, Wurzer C, Gabriel C, Redl H, Wolbank S. Enzymatic and non-enzymatic isolation systems for adipose tissue-derived cells: current state of the art. Cell Regen. 2015;4:7.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 85]  [Cited by in F6Publishing: 93]  [Article Influence: 10.3]  [Reference Citation Analysis (0)]
15.  Gimble JM, Guilak F, Bunnell BA. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther. 2010;1:19.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 193]  [Cited by in F6Publishing: 426]  [Article Influence: 30.4]  [Reference Citation Analysis (0)]
16.  Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47017]  [Cited by in F6Publishing: 45172]  [Article Influence: 3011.5]  [Reference Citation Analysis (0)]
17.  Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7:16.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1070]  [Cited by in F6Publishing: 1467]  [Article Influence: 86.3]  [Reference Citation Analysis (0)]
18.  US Department of Health and Human Services  OHAT Risk of Bias Rating Tool for Human and Animal Studies. Jan 2015. [cited 23 May 2024]. Available from: https://ntp.niehs.nih.gov/sites/default/files/ntp/ohat/pubs/riskofbiastool_508.pdf.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Kakagia D, Pallua N. Autologous fat grafting: in search of the optimal technique. Surg Innov. 2014;21:327-336.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 69]  [Cited by in F6Publishing: 78]  [Article Influence: 7.8]  [Reference Citation Analysis (0)]
20.  Kaufman MR, Bradley JP, Dickinson B, Heller JB, Wasson K, O'Hara C, Huang C, Gabbay J, Ghadjar K, Miller TA. Autologous fat transfer national consensus survey: trends in techniques for harvest, preparation, and application, and perception of short- and long-term results. Plast Reconstr Surg. 2007;119:323-331.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 184]  [Cited by in F6Publishing: 168]  [Article Influence: 9.9]  [Reference Citation Analysis (0)]
21.  Pak J, Lee JH, Pak N, Pak Y, Park KS, Jeon JH, Jeong BC, Lee SH. Cartilage Regeneration in Humans with Adipose Tissue-Derived Stem Cells and Adipose Stromal Vascular Fraction Cells: Updated Status. Int J Mol Sci. 2018;19.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 55]  [Article Influence: 9.2]  [Reference Citation Analysis (0)]
22.  van Dongen JA, Stevens HP, Harmsen MC, van der Lei B. Mechanical Micronization of Lipoaspirates: Squeeze and Emulsification Techniques. Plast Reconstr Surg. 2017;139:1369e-1370e.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 16]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
23.  Tocco I, Widgerow AD, Lalezari S, Banyard D, Shaterian A, Evans GR. Lipotransfer: the potential from bench to bedside. Ann Plast Surg. 2014;72:599-609.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
24.  Trivisonno A, Alexander RW, Baldari S, Cohen SR, Di Rocco G, Gentile P, Magalon G, Magalon J, Miller RB, Womack H, Toietta G. Intraoperative Strategies for Minimal Manipulation of Autologous Adipose Tissue for Cell- and Tissue-Based Therapies: Concise Review. Stem Cells Transl Med. 2019;8:1265-1271.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 64]  [Cited by in F6Publishing: 49]  [Article Influence: 9.8]  [Reference Citation Analysis (2)]
25.  Condé-Green A, Marano AA, Lee ES, Reisler T, Price LA, Milner SM, Granick MS. Fat Grafting and Adipose-Derived Regenerative Cells in Burn Wound Healing and Scarring: A Systematic Review of the Literature. Plast Reconstr Surg. 2016;137:302-312.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 96]  [Cited by in F6Publishing: 99]  [Article Influence: 12.4]  [Reference Citation Analysis (0)]
26.  Shanmugasundaram S, Vaish A, Chavada V, Murrell WD, Vaishya R. Assessment of safety and efficacy of intra-articular injection of stromal vascular fraction for the treatment of knee osteoarthritis-a systematic review. Int Orthop. 2021;45:615-625.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 24]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
27.  Copcu HE, Oztan S. Not Stromal Vascular Fraction (SVF) or Nanofat, but Total Stromal-Cells (TOST): A New Definition. Systemic Review of Mechanical Stromal-Cell Extraction Techniques. Tissue Eng Regen Med. 2021;18:25-36.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 21]  [Article Influence: 7.0]  [Reference Citation Analysis (0)]
28.  Nguyen A, Guo J, Banyard DA, Fadavi D, Toranto JD, Wirth GA, Paydar KZ, Evans GR, Widgerow AD. Stromal vascular fraction: A regenerative reality? Part 1: Current concepts and review of the literature. J Plast Reconstr Aesthet Surg. 2016;69:170-179.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 105]  [Cited by in F6Publishing: 131]  [Article Influence: 14.6]  [Reference Citation Analysis (0)]
29.  Kim SK. Adipose stromal vascular fraction isolation: a head-to-head comparison of four commercial cell separation systems. Plast Reconstr Surg. 2014;133:889e.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 3]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
30.  Marincola FM. Expression of concern: Clinical use of dieletrophoresis separation for live adipose derived stem cells. J Transl Med. 2014;12:297.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 2]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
31.  Raposio E, Caruana G, Bonomini S, Libondi G. A novel and effective strategy for the isolation of adipose-derived stem cells: minimally manipulated adipose-derived stem cells for more rapid and safe stem cell therapy. Plast Reconstr Surg. 2014;133:1406-1409.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 82]  [Article Influence: 8.2]  [Reference Citation Analysis (0)]
32.  Cohen SR, Tiryaki T, Womack HA, Canikyan S, Schlaudraff KU, Scheflan M. Cellular Optimization of Nanofat: Comparison of Two Nanofat Processing Devices in Terms of Cell Count and Viability. Aesthet Surg J Open Forum. 2019;1:ojz028.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 30]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
33.  Sesé B, Sanmartín JM, Ortega B, Matas-Palau A, Llull R. Nanofat Cell Aggregates: A Nearly Constitutive Stromal Cell Inoculum for Regenerative Site-Specific Therapies. Plast Reconstr Surg. 2019;144:1079-1088.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 45]  [Article Influence: 11.3]  [Reference Citation Analysis (0)]
34.  Bianchi F, Maioli M, Leonardi E, Olivi E, Pasquinelli G, Valente S, Mendez AJ, Ricordi C, Raffaini M, Tremolada C, Ventura C. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant. 2013;22:2063-2077.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 185]  [Cited by in F6Publishing: 200]  [Article Influence: 16.7]  [Reference Citation Analysis (0)]
35.  Bright R, Bright M, Bright P, Hayne S, Thomas WD. Migraine and tension-type headache treated with stromal vascular fraction: a case series. J Med Case Rep. 2014;8:237.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 11]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
36.  Gentile P, Scioli MG, Orlandi A, Cervelli V. Breast Reconstruction with Enhanced Stromal Vascular Fraction Fat Grafting: What Is the Best Method? Plast Reconstr Surg Glob Open. 2015;3:e406.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 67]  [Cited by in F6Publishing: 78]  [Article Influence: 8.7]  [Reference Citation Analysis (0)]
37.  Chaput B, Bertheuil N, Escubes M, Grolleau JL, Garrido I, Laloze J, Espagnolle N, Casteilla L, Sensebé L, Varin A. Mechanically Isolated Stromal Vascular Fraction Provides a Valid and Useful Collagenase-Free Alternative Technique: A Comparative Study. Plast Reconstr Surg. 2016;138:807-819.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 42]  [Cited by in F6Publishing: 43]  [Article Influence: 6.1]  [Reference Citation Analysis (0)]
38.  Copcu HE, Oztan S. New Mechanical Fat Separation Technique: Adjustable Regenerative Adipose-tissue Transfer (ARAT) and Mechanical Stromal Cell Transfer (MEST). Aesthet Surg J Open Forum. 2020;2:ojaa035.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 12]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
39.  Rose JG Jr, Lucarelli MJ, Lemke BN, Dortzbach RK, Boxrud CA, Obagi S, Patel S. Histologic comparison of autologous fat processing methods. Ophthalmic Plast Reconstr Surg. 2006;22:195-200.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 57]  [Cited by in F6Publishing: 60]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
40.  Amirkhani MA, Mohseni R, Soleimani M, Shoae-Hassani A, Nilforoushzadeh MA. A rapid sonication based method for preparation of stromal vascular fraction and mesenchymal stem cells from fat tissue. Bioimpacts. 2016;6:99-104.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 15]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
41.  Victor S  Ultrasonic cavitation derived stromal or mesenchymal vascular extracts and cells derived therefrom obtained from adipose tissue and use thereof. 2023. [cited 23 May 2024]. Available from: https://patents.google.com/patent/US8440440B2/en.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Domenis R, Lazzaro L, Calabrese S, Mangoni D, Gallelli A, Bourkoula E, Manini I, Bergamin N, Toffoletto B, Beltrami CA, Beltrami AP, Cesselli D, Parodi PC. Adipose tissue derived stem cells: in vitro and in vivo analysis of a standard and three commercially available cell-assisted lipotransfer techniques. Stem Cell Res Ther. 2015;6:2.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 78]  [Cited by in F6Publishing: 85]  [Article Influence: 9.4]  [Reference Citation Analysis (0)]
43.  Condé-Green A, Baptista LS, de Amorin NF, de Oliveira ED, da Silva KR, Pedrosa Cda S, Borojevic R, Pitanguy I. Effects of centrifugation on cell composition and viability of aspirated adipose tissue processed for transplantation. Aesthet Surg J. 2010;30:249-255.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 86]  [Cited by in F6Publishing: 72]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
44.  Markarian CF, Frey GZ, Silveira MD, Chem EM, Milani AR, Ely PB, Horn AP, Nardi NB, Camassola M. Isolation of adipose-derived stem cells: a comparison among different methods. Biotechnol Lett. 2014;36:693-702.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 78]  [Cited by in F6Publishing: 64]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
45.  Shah FS, Wu X, Dietrich M, Rood J, Gimble JM. A non-enzymatic method for isolating human adipose tissue-derived stromal stem cells. Cytotherapy. 2013;15:979-985.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 85]  [Cited by in F6Publishing: 86]  [Article Influence: 7.8]  [Reference Citation Analysis (0)]
46.  Condé-Green A, de Amorim NF, Pitanguy I. Influence of decantation, washing and centrifugation on adipocyte and mesenchymal stem cell content of aspirated adipose tissue: a comparative study. J Plast Reconstr Aesthet Surg. 2010;63:1375-1381.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 157]  [Cited by in F6Publishing: 170]  [Article Influence: 12.1]  [Reference Citation Analysis (0)]
47.  Baptista LS, do Amaral RJ, Carias RB, Aniceto M, Claudio-da-Silva C, Borojevic R. An alternative method for the isolation of mesenchymal stromal cells derived from lipoaspirate samples. Cytotherapy. 2009;11:706-715.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 75]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
48.  Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. J Med Case Rep. 2011;5:296.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 152]  [Cited by in F6Publishing: 167]  [Article Influence: 12.8]  [Reference Citation Analysis (0)]
49.  Goodarzi P, Alavi-Moghadam S, Sarvari M, Tayanloo Beik A, Falahzadeh K, Aghayan H, Payab M, Larijani B, Gilany K, Rahim F, Adibi H, Arjmand B. Adipose Tissue-Derived Stromal Cells for Wound Healing. Adv Exp Med Biol. 2018;1119:133-149.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 38]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
50.  Andjelkov K, Sforza M, Barisic G, Soldatovic I, Hiranyakas A, Krivokapic Z. A novel method for treatment of chronic anal fissure: adipose-derived regenerative cells - a pilot study. Colorectal Dis. 2017;19:570-575.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 18]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
51.  Chulpanova DS, Kitaeva KV, Tazetdinova LG, James V, Rizvanov AA, Solovyeva VV. Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment. Front Pharmacol. 2018;9:259.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 91]  [Cited by in F6Publishing: 116]  [Article Influence: 19.3]  [Reference Citation Analysis (0)]
52.  United States Department of Health and Human Services  Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use. Jul 2020. [cited 23 May 2024]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/regulatory-considerations-human-cells-tissues-and-cellular-and-tissue-based-products-minimal.  [PubMed]  [DOI]  [Cited in This Article: ]
53.  McArdle A, Senarath-Yapa K, Walmsley GG, Hu M, Atashroo DA, Tevlin R, Zielins E, Gurtner GC, Wan DC, Longaker MT. The role of stem cells in aesthetic surgery: fact or fiction? Plast Reconstr Surg. 2014;134:193-200.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 33]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
54.  Romanov YA, Darevskaya AN, Merzlikina NV, Buravkova LB. Mesenchymal stem cells from human bone marrow and adipose tissue: isolation, characterization, and differentiation potentialities. Bull Exp Biol Med. 2005;140:138-143.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 126]  [Cited by in F6Publishing: 111]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
55.  Osinga R, Menzi NR, Tchang LAH, Caviezel D, Kalbermatten DF, Martin I, Schaefer DJ, Scherberich A, Largo RD. Effects of intersyringe processing on adipose tissue and its cellular components: implications in autologous fat grafting. Plast Reconstr Surg. 2015;135:1618-1628.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 48]  [Article Influence: 5.3]  [Reference Citation Analysis (0)]
56.  Condé-green A, Rodriguez RL, Slezak S, Singh DP, Goldberg NH, Mclenithan J. Comparison between Stromal Vascular Cells’ Isolation with Enzymatic Digestion and Mechanical Processing of Aspirated Adipose Tissue. Plast Reconstr Surg. 2014;134:54.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 22]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
57.  Aronowitz JA, Lockhart RA, Hakakian CS, Hicok KC. Clinical Safety of Stromal Vascular Fraction Separation at the Point of Care. Ann Plast Surg. 2015;75:666-671.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 29]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
58.  Navarro A, Marín S, Riol N, Carbonell-Uberos F, Miñana MD. Human adipose tissue-resident monocytes exhibit an endothelial-like phenotype and display angiogenic properties. Stem Cell Res Ther. 2014;5:50.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 22]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
59.  Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, Sato K, Inoue K, Nagase T, Koshima I, Gonda K. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol. 2006;208:64-76.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 582]  [Cited by in F6Publishing: 560]  [Article Influence: 31.1]  [Reference Citation Analysis (0)]
60.  Coleman SR, Katzel EB. Fat Grafting for Facial Filling and Regeneration. Clin Plast Surg. 2015;42:289-300, vii.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 110]  [Cited by in F6Publishing: 99]  [Article Influence: 11.0]  [Reference Citation Analysis (0)]